EXOSC8 (C-term), 243-276 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-EXOSC8 (C-term), 243-276 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | EXOSC8 (C-term), 243-276 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 2 |
| Applications | Flow Cytometry (FC/FACS), ELISA (EIA), Western Blot (WB), Immunohistochemistry (IHC) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This EXOSC8 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 243-276 amino acids from the C-terminal region of human EXOSC8. EXOSC8 is a component of the exosome 3'->5' exoribonuclease complex, a complex that degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3'-untranslated regions. It is required for the 3'-processing of the 7S pre-RNA to the mature 5.8S rRNA and has a 3'-5' exonuclease activity. |
| Immunogen | n/a |
| Other Names | [Exosome complex component RRP43; Exosome component 8; Opa-interacting protein 2; OIP-2; Ribosomal RNA-processing protein 43; p9; EXOSC8; OIP2; RRP43] |
| Gene, Accession # | [EXOSC8], Gene ID: 11340, NCBI: NP_852480.1, UniProt: Q96B26 |
| Catalog # | MBS9204531 |
| Price | $165, $370 |
| Order / More Info | EXOSC8 (C-term), 243-276 Antibody from MYBIOSOURCE INC. |
| Product Specific References | Raijmakers,R., J. Mol. Biol. 323 (4), 653-663 (2002) Jiang,T., Proc. Natl. Acad. Sci. U.S.A. 99 (8), 5295-5300 (2002) Raijmakers,R., J. Mol. Biol. 315 (4), 809-818 (2002) Brouwer,R., J. Biol. Chem. 276 (9), 6177-6184 (2001) |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies